Jump to ContentJump to Main Navigation
Show Summary Details
In This Section

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982

Online
ISSN
1437-4331
See all formats and pricing
In This Section
Volume 43, Issue 10 (Oct 2005)

Issues

Concentrations of homocysteine, related metabolites and asymmetric dimethylarginine in preeclamptic women with poor nutritional status

Wolfgang Herrmann
  • Department of Clinical Chemistry, Faculty of Medicine, University Hospital of Saarland, Homburg/Saar, Germany
/ Sonia Isber
  • Department of Clinical Chemistry, Faculty of Medicine, University Hospital of Saarland, Homburg/Saar, Germany
/ Rima Obeid
  • Department of Clinical Chemistry, Faculty of Medicine, University Hospital of Saarland, Homburg/Saar, Germany
/ Markus Herrmann
  • Department of Clinical Chemistry, Faculty of Medicine, University Hospital of Saarland, Homburg/Saar, Germany
/ Muhidien Jouma
  • Department of Clinical Biochemistry, Faculty of Pharmacy, Damascus University, Damascus, Syria
Published Online: 2011-09-21 | DOI: https://doi.org/10.1515/CCLM.2005.198

Abstract

Background: Hyperhomocysteinemia, a proxy measure for the nutritional status of the B vitamins, may be involved in the etiology of preeclampsia via inducing endothelial dysfunction. Asymmetric dimethylarginine (ADMA) is an inhibitor of NO-synthase that may adversely affect the endothelium.

Materials and methods: We investigated serum concentrations of folate, vitamin B12, B6, homocysteine (Hcy) and related metabolites in 139 Syrian preeclamptic women and 93 asymptomatic pregnant women of comparable age, gestational age and socioeconomic status. Plasma concentrations of ADMA were determined in a subset of age- and gestation-age-matched pairs of patients and controls (n=63).

Results: Higher concentrations of Hcy, cystathionine and methylmalonic acid (MMA) were closely linked to a lower status of the B vitamins. Higher concentrations of Hcy and cystathionine were observed in the preeclamptic group than in the matched controls (median Hcy 9.3 vs. 6.0μmol/L; median cystathionine 284 vs. 232nmol/L). Serum folate was significantly lower in patients than in controls (16.4 vs. 36.0nmol/L). Folate supplementation was less likely to be used in preeclamptic women. Concentrations of MMA were elevated in patients and controls and did not differ significantly between the two groups. Median plasma concentrations of ADMA were significantly lower in asymptomatic women than in those who developed preeclampsia before the 37th week of gestation (0.61 vs. 0.68μmol/L).

Conclusions: Elevated serum concentrations of Hcy, cystathionine and MMA indicate poor status of the B vitamins during pregnancy. The adverse effect of Hcy on endothelial function might be related to ADMA in early-onset preeclampsia. More emphasis should be placed on increasing the intake of B vitamins in pregnant women from developing countries.

Keywords: asymmetric dimethylarginine; folate; homocysteine; preeclampsia

References

  • 1.

    MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001; 97:533–8.Google Scholar

  • 2.

    Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001; 357:53–6.Google Scholar

  • 3.

    Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK, et al. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr 2000; 71:962–8.Google Scholar

  • 4.

    Ray JG, Laskin CA. Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review. Placenta 1999; 20:519–29.CrossrefGoogle Scholar

  • 5.

    Andersson A, Hultberg B, Brattstrom L, Isaksson A. Decreased serum homocysteine in pregnancy. Eur J Clin Chem Clin Biochem 1992; 30:377–9.Google Scholar

  • 6.

    Murphy MM, Scott JM, Arija V, Molloy AM, Fernandez-Ballart JD. Maternal homocysteine before conception and throughout pregnancy predicts fetal homocysteine and birth weight. Clin Chem 2004; 50:1406–12.CrossrefGoogle Scholar

  • 7.

    Murphy MM, Scott JM, McPartlin JM, Fernandez-Ballart JD. The pregnancy-related decrease in fasting plasma homocysteine is not explained by folic acid supplementation, hemodilution, or a decrease in albumin in a longitudinal study. Am J Clin Nutr 2002; 76:614–9.Google Scholar

  • 8.

    Cikot RJ, Steegers-Theunissen RP, Thomas CM, de Boo TM, Merkus HM, Steegers EA. Longitudinal vitamin and homocysteine levels in normal pregnancy. Br J Nutr 2001; 85:49–58.CrossrefGoogle Scholar

  • 9.

    Steegers-Theunissen RP, Boers GH, Blom HJ, Trijbels FJ, Eskes TK. Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae. Lancet 1992; 339:1122–3.Google Scholar

  • 10.

    Austin RC, Lentz SR, Werstuck GH. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ 2004; 11(Suppl 1):S56–64.CrossrefGoogle Scholar

  • 11.

    Powers RW, Evans RW, Majors AK, Ojimba JI, Ness RB, Crombleholme WR, et al. Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol 1998; 179:1605–11.Google Scholar

  • 12.

    Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161:1200–4.Google Scholar

  • 13.

    Powers RW, Evans RW, Ness RB, Crombleholme WR, Roberts JM. Homocysteine and cellular fibronectin are increased in preeclampsia, not transient hypertension of pregnancy. Hypertens Pregnancy 2001; 20:69–77.CrossrefGoogle Scholar

  • 14.

    Sanchez SE, Zhang C, Rene Malinow M, Ware-Jauregui S, Larrabure G, Williams MA. Plasma folate, vitamin B(12), and homocyst(e)ine concentrations in preeclamptic and normotensive Peruvian women. Am J Epidemiol 2001; 153:474–80.Google Scholar

  • 15.

    Cotter AM, Molloy AM, Scott JM, Daly SF. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol 2001; 185:781–5.Google Scholar

  • 16.

    Savvidou MD, Hingorani AD, Tsikas D, Frolich JC, Vallance P, Nicolaides KH. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 2003; 361:1511–7.Google Scholar

  • 17.

    Stuhlinger MC, Oka RK, Graf EE, Schmolzer I, Upson BM, Kapoor O, et al. Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethyl-arginine. Circulation 2003; 108:933–8.Google Scholar

  • 18.

    Minkauskiene M, Nadisauskiene R, Padaiga Z, Makari S. Systematic review on the incidence and prevalence of severe maternal morbidity. Medicina (Kaunas) 2004; 40:299–309.Google Scholar

  • 19.

    Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin Americaand the Caribbean. Br J Obstet Gynaecol 1992; 99:547–53.Google Scholar

  • 20.

    Bakour SH, Nassif B, Nwosu EC. Outcome of ruptured uterus at university teaching hospital Aleppo, Syria. J Obstet Gynecol 1998; 15:424–8.Google Scholar

  • 21.

    Herrmann W, Obeid R, Jouma M. Hyperhomocysteinemia and vitamin B-12 deficiency are more striking in Syrians than in Germans – causes and implications. Atherosclerosis 2003; 166:143–50.Google Scholar

  • 22.

    Obeid R, Jouma M, Herrmann W. Cobalamin status (holo-transcobalamin, methylmalonic acid) and folate as determinants of homocysteine concentration. Clin Chem 2002; 48:2064–5.Google Scholar

  • 23.

    Schulze F, Wesemann R, Schwedhelm E, Sydow K, Albsmeier J, Cooke JP, et al. Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clin Chem Lab Med 2004; 42:1377–83.Google Scholar

  • 24.

    Ronnenberg AG, Goldman MB, Chen D, Aitken IW, Willett WC, Selhub J, Xu X. Preconception folate and vitamin B(6) status and clinical spontaneous abortion in Chinese women. Obstet Gynecol 2002; 100:107–13.Google Scholar

  • 25.

    Ronnenberg AG, Goldman MB, Chen D, Aitken IW, Willett WC, Selhub J, Xu X. Preconception homocysteine and B vitamin status and birth outcomes in Chinese women. Am J Clin Nutr 2002; 76:1385–91.Google Scholar

  • 26.

    Adams MJ Jr, Khoury MJ, Scanlon KS, Stevenson RE, Knight GJ, Haddow JE, et al. Elevated midtrimester serum methylmalonic acid levels as a risk factor for neural tube defects. Teratology 1995; 51:311–7.CrossrefGoogle Scholar

  • 27.

    Bjorke Monsen AL, Ueland PM, Vollset SE, Guttormsen AB, Markestad T, Solheim E, et al. Determinants of cobalamin status in newborns. Pediatrics 2001; 108:624–30.CrossrefGoogle Scholar

  • 28.

    McMullin MF, Young PB, Bailie KE, Savage GA, Lappin TR, White R. Homocysteine and methylmalonic acid as indicators of folate and vitamin B12 deficiency in pregnancy. Clin Lab Haematol 2001; 23:161–5.CrossrefGoogle Scholar

  • 29.

    Bondevik GT, Schneede J, Refsum H, Lie RT, Ulstein M, Kvale G. Homocysteine and methylmalonic acid levels in pregnant Nepali women. Should cobalamin supplementation be considered? Eur J Clin Nutr 2001; 55:856–64.Google Scholar

  • 30.

    Guerra-Shinohara EM, Morita OE, Peres S, Pagliusi RA, Sampaio Neto LF, D'Almeida V, et al. Low ratio of S-adenosylmethionine to S-adenosylhomocysteine is associated with vitamin deficiency in Brazilian pregnant women and newborns. Am J Clin Nutr 2004; 80:1312–21.Google Scholar

  • 31.

    Maas R, Boger RH, Schwedhelm E, Casas JP, Lopez-Jaramillo P, Serrano N. Plasma concentrations of asymmetric dimethylarginine (ADMA) in Colombian women with pre-eclampsia. J Am Med Assoc 2004; 291:823–4.Google Scholar

  • 32.

    Sorensen TK, Malinow MR, Williams MA, King IB, Luthy DA. Elevated second-trimester serum homocyst(e)ine levels and subsequent risk of preeclampsia. Gynecol Obstet Invest 1999; 48:98–103.Google Scholar

  • 33.

    Herrmann W, Schorr H, Obeid R, Geisel J. Vitamin B-12 status, particularly holotranscobalamin II and methylmalonic acid concentrations, and hyperhomocysteinemia in vegetarians. Am J Clin Nutr 2003; 78:131–6.Google Scholar

  • 34.

    Tefferi A, Pruthi RK. The biochemical basis of cobalamin deficiency. Mayo Clin Proc 1994; 69:181–6.Google Scholar

  • 35.

    Laurence KM, James N, Miller M, Campbell H. Increased risk of recurrence of pregnancies complicated by fetal neural tube defects in mothers receiving poor diets, and possible benefit of dietary counselling. Br Med J 1980; 281:1592–4.Google Scholar

  • 36.

    Roberts JM, Balk JL, Bodnar LM, Belizan JM, Bergel E, Martinez A. Nutrient involvement in preeclampsia. J Nutr 2003; 133(Suppl 2):1684S–92S.Google Scholar

  • 37.

    Herrmann W, Hubner U, Koch I, Obeid R, Retzke U, Geisel J. Alteration of homocysteine catabolism in pre-eclampsia, HELLP syndrome and placental insufficiency. Clin Chem Lab Med 2004; 42:1109–16.Google Scholar

  • 38.

    Wannous S, Arous S. Incidence and determinants of low birth weight in Syrian government hospitals. East Mediterr Health J 2001; 7:966–74.Google Scholar

About the article

Corresponding author: Prof. Dr. Wolfgang Herrmann, Zentrallabor der Universitätskliniken des Saarlandes, Gebäude 57, 66421 Homburg, Germany Phone: +49-6841-1630700, Fax: +49-6841-1630703,


Published Online: 2011-09-21

Published in Print: 2005-10-01


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2005.198.

Export Citation

©2005 by Walter de Gruyter Berlin New York. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Keizo Kanasaki and Megumi Kanasaki
Hypertension Research in Pregnancy, 2013, Volume 1, Number 2, Page 57
[3]
Shi Wu Wen, Josee Champagne, Ruth Rennicks White, Doug Coyle, William Fraser, Graeme Smith, Dean Fergusson, and Mark C. Walker
Journal of Pregnancy, 2013, Volume 2013, Page 1
[4]
Ranwa Alsayed, Faizeh AL Quobaili, Samir Srour, Jürgen Geisel, and Rima Obeid
Metabolism, 2013, Volume 62, Number 8, Page 1074
[5]
B. Demir, S. Demir, S. Pasa, S. Guven, Y. Atamer, A. Atamer, and Y. Kocyigit
Journal of Obstetrics & Gynaecology, 2012, Volume 32, Number 6, Page 525
[6]
Kristin Braekke, Per M Ueland, Nina K Harsem, and Anne Cathrine Staff
Pediatric Research, 2009, Volume 66, Number 4, Page 411
[7]
James M. Roberts, Lisa M. Bodnar, Thelma E. Patrick, and Robert W. Powers
Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health, 2011, Volume 1, Number 1, Page 6
[8]
Vivek Shenoy, Keizo Kanasaki, and Raghu Kalluri
Trends in Endocrinology & Metabolism, 2010, Volume 21, Number 9, Page 529
[9]
Wolfgang Herrmann
Clinical Chemical Laboratory Medicine, 2005, Volume 43, Number 10
[10]
Dongwei Mao, Jianhua Che, Keshen Li, Shiyu Han, Qi Yue, Li Zhu, Wei Zhang, and Lin Li
Archives of Gynecology and Obstetrics, 2010, Volume 282, Number 4, Page 371

Comments (0)

Please log in or register to comment.
Log in